| scholarly article | Q13442814 |
| P50 | author | Christopher John Lindsell | Q42094343 |
| P2093 | author name string | Eric P Smith | |
| Robert M Cohen | |||
| Robert S Franco | |||
| Clinton H Joiner | |||
| Anthony Carruthers | |||
| Paramjit K Khera | |||
| Yancey R Holmes | |||
| P2860 | cites work | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 |
| Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy | Q28219172 | ||
| The clinical information value of the glycosylated hemoglobin assay | Q28272079 | ||
| Net sugar transport is a multistep process. Evidence for cytosolic sugar binding sites in erythrocytes | Q28284560 | ||
| Asymmetry of hexose transfer system in erythrocytes of fetal and new-born guinea-pigs | Q28368035 | ||
| Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: an analysis of data from the Diabetes Control and Complications Trial | Q33232624 | ||
| HbA1c standardisation destination--global IFCC Standardisation. How, why, where and when--a tortuous pathway from kit manufacturers, via inter-laboratory lyophilized and whole blood comparisons to designated national comparison schemes. | Q34055861 | ||
| Solvent water in the mammalian erythrocyte | Q34568139 | ||
| Ascorbate function and metabolism in the human erythrocyte | Q34743888 | ||
| Tests of glycemia in diabetes | Q35818970 | ||
| Nonsolvent Water in Human Erythrocytes | Q36427531 | ||
| Facilitated diffusion of glucose | Q37969161 | ||
| ATP-dependent substrate occlusion by the human erythrocyte sugar transporter | Q38314488 | ||
| The human erythrocyte sugar transporter presents two sugar import sites | Q38317309 | ||
| Quench-flow analysis reveals multiple phases of GluT1-mediated sugar transport | Q38330655 | ||
| Comparative evaluation of fifteen anti-sickling agents | Q40146100 | ||
| Compartmentalization of sickle-cell calcium in endocytic inside-out vesicles | Q41500350 | ||
| Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose-transporter-protein syndrome | Q41925753 | ||
| ATP regulation of the human red cell sugar transporter | Q42221470 | ||
| ATP-dependent sugar transport complexity in human erythrocytes | Q42780800 | ||
| HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins | Q43808973 | ||
| Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial | Q43869392 | ||
| High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control | Q44117447 | ||
| Vagotomy attenuates effects of L-glucose but not of D-glucose on spontaneous alternation performance | Q44207221 | ||
| In plants, 3-o-methylglucose is phosphorylated by hexokinase but not perceived as a sugar | Q44315494 | ||
| Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes: response to McCarter et al. | Q44377179 | ||
| Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes | Q44909487 | ||
| Glycosylated hemoglobin in human and animal red cells. Role of glucose permeability | Q46058989 | ||
| Properties of the human erythrocyte glucose transport protein are determined by cellular context | Q46431878 | ||
| A comparison of the Glycosylation Gap and Hemoglobin Glycation Index in patients with diabetes | Q46579589 | ||
| A1C: does one size fit all? | Q47268442 | ||
| Facilitated transport of glucose from blood into peripheral nerve | Q48456474 | ||
| Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid | Q49140908 | ||
| Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. | Q51575807 | ||
| Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins. | Q51793484 | ||
| The Hemoglobin Glycation Index Is Not an Independent Predictor of the Risk of Microvascular Complications in the Diabetes Control and Complications Trial | Q57491790 | ||
| Relationship of Prospective GHb to Glycated Serum Proteins in Incident Diabetic Retinopathy: Implications of the glycation gap for mechanism of risk prediction | Q61870357 | ||
| Modulation of ouabain binding and potassium pump fluxes by cellular sodium and potassium in human and sheep erythrocytes | Q67418800 | ||
| Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia | Q68802259 | ||
| Anomalous asymmetric kinetics of human red cell hexose transfer: role of cytosolic adenosine 5'-triphosphate | Q69540302 | ||
| Phosphorylation of 3-O-methyl-D-glucose by yeast and beef hexokinase | Q70029248 | ||
| Phosphorylation of glucose analog 3-O-methyl-D-glucose by rat heart | Q71319807 | ||
| Human erythrocyte sugar transport is incompatible with available carrier models | Q71395205 | ||
| Measurement of the hemoglobin concentration in deoxyhemoglobin S polymers and characterization of the polymer water compartment | Q72819677 | ||
| Human erythrocytes express GLUT5 and transport fructose | Q73374189 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2445-2452 | |
| P577 | publication date | 2008-06-30 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation | |
| P478 | volume | 57 |
| Q43740705 | A semi-mechanistic model of the relationship between average glucose and HbA1c in healthy and diabetic subjects |
| Q43235338 | A1C: recommendations, debates, and questions. |
| Q87615366 | Are glycated serum proteins ready for prime time? |
| Q37193623 | Association of glycation gap with mortality and vascular complications in diabetes. |
| Q37404625 | Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications |
| Q38129464 | Biological variation and hemoglobin A1c: relevance to diabetes management and complications |
| Q26996480 | Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers |
| Q42920363 | Blood viscosity, lipid profile, and lipid peroxidation in type-1 diabetic patients with good and poor glycemic control |
| Q92715875 | Comparative Abilities of Fasting Plasma Glucose and Haemoglobin A1c in Predicting Metabolic Syndrome among Apparently Healthy Normoglycemic Ghanaian Adults |
| Q37983923 | Current controversies in the use of haemoglobin A1c. |
| Q83358851 | Current literature in diabetes |
| Q39160771 | Current therapeutic approaches in the management of hyperglycemia in chronic renal disease. |
| Q37694160 | DNA Advanced Glycation End Products (DNA-AGEs) Are Elevated in Urine and Tissue in an Animal Model of Type 2 Diabetes. |
| Q33688393 | Differences in Red Blood Cell Indices Do Not Explain Racial Disparity in Hemoglobin A1c in Children with Type 1 Diabetes |
| Q47547696 | Distribution of glycated haemoglobin and its determinants in Korean youth and young adults: a nationwide population-based study |
| Q37638849 | Effect of ethnicity on HbA1c levels in individuals without diabetes: Systematic review and meta-analysis |
| Q36284084 | Effects of flaxseed oil on anti-oxidative system and membrane deformation of human peripheral blood erythrocytes in high glucose level |
| Q41624898 | Ethnic/racial determinants of glycemic markers in a UK sample. |
| Q47756501 | Evaluation of the Sebia Capillarys 3 Tera and the Bio-Rad D-100 Systems for the Measurement of Hemoglobin A1c. |
| Q35123412 | Evidence for consistency of the glycation gap in diabetes |
| Q35390039 | Glucoregulatory function among African Americans and European Americans with normal or pre-diabetic hemoglobin A1c levels |
| Q36868263 | Glucose-independent ethnic differences in HbA1c in people without known diabetes |
| Q51056813 | Glycated hemoglobin is not an accurate indicator of glycemia in rainbow trout. |
| Q92250339 | Gold nano-flowers (Au NFs) modified screen-printed carbon electrode electrochemical biosensor for label-free and quantitative detection of glycated hemoglobin |
| Q38036145 | HbA1c for screening and diagnosis of diabetes mellitus |
| Q42331648 | HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction? |
| Q46436882 | Hemoglobin A1C Criterion for Diabetes Diagnosis Among Hispanic and Non-Hispanic Populations |
| Q34538219 | Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population. |
| Q33602143 | Labile A1C is inversely correlated with the hemoglobin glycation index in children with type 1 diabetes |
| Q35882891 | Marked increase in rat red blood cell membrane protein glycosylation by one-month treatment with a cafeteria diet. |
| Q33727475 | Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters |
| Q34655515 | Monitoring HIV-infected Patients with Diabetes: Hemoglobin A1c, Fructosamine, or Glucose? |
| Q35775471 | Oral supplementation of diabetic mice with propolis restores the proliferation capacity and chemotaxis of B and T lymphocytes towards CCL21 and CXCL12 by modulating the lipid profile, the pro-inflammatory cytokine levels and oxidative stress |
| Q42096270 | Physiologic Concepts That May Revise the Interpretation and Implications of HbA1C in Clinical Medicine: An American Perspective |
| Q42948845 | Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum |
| Q35869552 | Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes |
| Q88887505 | Racial disparity in HbA1c persists when fructosamine is used as a surrogate for mean blood glucose in youth with type 1 diabetes |
| Q36969806 | Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c |
| Q33556890 | Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study |
| Q43990488 | Repeat measurements of glycated haemoglobin A(1c) and N-terminal pro-B-type natriuretic peptide: divergent behaviour in diabetes mellitus |
| Q37798056 | Review of hemoglobin A1c in the management of diabetes |
| Q36197966 | Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis |
| Q35841172 | Spuriously high prevalence of prediabetes diagnosed by HbA(1c) in young indians partly explained by hematological factors and iron deficiency anemia. |
| Q34515118 | Supplementary use of HbA1c as hyperglycemic criterion to detect metabolic syndrome |
| Q99406722 | The Sickle Effect: The Silent Titan Affecting Glycated Hemoglobin Reliability |
| Q100750541 | The trials and tribulations of determining HbA1c targets for diabetes mellitus |
| Q61448561 | Update on biomarkers of glycemic control |
| Q34772031 | Use of an oral stable isotope label to confirm variation in red blood cell mean age that influences HbA1c interpretation |
| Q28533840 | Variables involved in the discordance between HbA1c and fructosamine: the glycation gap revisited |
| Q36302225 | What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes? |
| Q36426844 | When the blood glucose and the HbA(1c) don't match: turning uncertainty into opportunity. |
Search more.